WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000024400) USE OF OPTICALLY PURE (R)-TOFISOPAM FOR TREATING AND PREVENTING ANXIETY DISORDERS AND COMPOSITION THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/024400    International Application No.:    PCT/US1999/025040
Publication Date: 04.05.2000 International Filing Date: 27.10.1999
Chapter 2 Demand Filed:    23.05.2000    
IPC:
A61K 31/551 (2006.01)
Applicants: VELA PHARMACEUTICALS INC. [US/US]; 3131 Princeton Pike, Building 4, Suite 216, Lawrenceville, NJ 08648 (US) (For All Designated States Except US).
LANDRY, Donald, W. [US/US]; (US) (For US Only).
KLEIN, Donald, F. [US/US]; (US) (For US Only)
Inventors: LANDRY, Donald, W.; (US).
KLEIN, Donald, F.; (US)
Agent: HALEY, James, F., Jr.; Fish & Neave, 1251 Avenue of the Americas, New York, NY 10020 (US).
VOSSIUS & PARTNER (No. 31); Siebertstr. 4, D-81675 München (DE)
Priority Data:
60/105,803 27.10.1998 US
Title (EN) USE OF OPTICALLY PURE (R)-TOFISOPAM FOR TREATING AND PREVENTING ANXIETY DISORDERS AND COMPOSITION THEREOF
(FR) UTILISATION DU TOFISOPAM (R) OPTIQUEMENT PUR POUR TRAITER ET PREVENIR LES TROUBLES DE L'ANXIETE ET SA COMPOSITION
Abstract: front page image
(EN)Methods are disclosed utilizing the R enantiomer of tofisopam. This compound is useful in the treatment or prevention of anxiety or anxiety disorders while substantially reducing adverse effects associated with racemic tofisopam.
(FR)L'invention concerne des procédés utilisant un énantiomère R de tofisopam. Ce composé est utile pour traiter ou prévenir l'anxiété ou les troubles de l'anxiété, tout en réduisant sensiblement les effets secondaires liés au tofisopam racémique.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)